secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001664710-25-000010
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Keros CEO Jasbir Seehra to present at Guggenheim SMID Cap Biotech Conference on Feb 6
--------------------------------------------------------------------------------

- Chair and CEO Jasbir Seehra will participate in a fireside chat at the Guggenheim SMID Cap Biotech Conference.
- Presentation scheduled for Thursday, February 6, 2025, at 10:00 a.m. Eastern time.
- Live webcast and 90-day replay available via Keros investor relations page.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471025000010/0001664710-25-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471025000010/kros-20250130.htm
  HTML page:      https://secwatch.observer/filing/0001664710-25-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer